Article Details
Retrieved on: 2018-02-05 15:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>The company has so far raised $100 million; investors include Flagship Pioneering, <b>Google Ventures</b> and Mayo Clinic. Evelo's remit goes beyond cancer. The company is currently investigating treatments for multiple sclerosis, rheumatoid arthritis, asthma, inflammatory bowel disease and diabetes, ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here